高级检索
当前位置: 首页 > 详情页

The thermogenic activity of adjacent adipocytes fuels the progression of ccRCC and compromises anti-tumor therapeutic efficacy

文献详情

资源类型:
WOS体系:

收录情况: ◇ 自然指数

机构: [1]Shanghai Jiao Tong Univ,Key Lab Cell Differentiat & Apoptosis Chinese,Dept Endocrinol & Metab,Minist Educ,Shanghai Diabet Inst,Affiliated Peoples Hosp 6,Shanghai 200032,Peoples R China [2]Naval Med Univ, Changhai Hosp, Dept Urol, Shanghai 200433, Peoples R China [3]Kunming Med Univ, Dept Urol, Yanan Affiliated Hosp, Kunming 650051, Yunnan, Peoples R China [4]Fudan Univ, Zhongshan Hosp, Metabon & Syst Biol Lab,Shanghai Int Ctr Mol Phen, Sch Life Sci,State Key Lab Genet Engn,Human Pheno, Shanghai 200438, Peoples R China [5]Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China [6]Shanghai Univ Sport, Sch Kinesiol, Shanghai 200438, Peoples R China [7]East China Normal Univ, Sch Life Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China
出处:
ISSN:

关键词: ADIPOSE-TISSUE TARGETED THERAPY CANCER FAT HOMEOSTASIS OBESITY WHITE METABOLISM RESISTANCE ENERGY

摘要:
Clear cell renal cell carcinoma (ccRCC) preferentially invades into perinephric adipose tissue (PAT), a process associated with poor prognosis. However, the detailed mechanisms underlying this interaction remain elusive. Here, we describe a bi-directional communication between ccRCC cells and the PAT. We found that ccRCC cells secrete parathyroid-hormone-related protein (PTHrP) to promote the browning of PAT by PKA activation, while PAT-mediated thermogenesis results in the release of excess lactate to enhance ccRCC growth, invasion, and metastasis. Further, tyrosine kinase inhibitors (TKIs) extensively used in the treatment of ccRCC enhanced this vicious cycle of ccRCC-PAT communication by promoting the browning of PAT. However, if this cross-communication was short circuited by the pharmacological suppression of adipocyte browning via H89 or KT5720, the anti-tumor efficacy of the TKI, sunitinib, was enhanced. These results suggest that ccRCC-PAT cross-communication has important clinical relevance, and use of combined therapy holds great promise in enhancing the efficacy of TKIs.

基金编号: SHDC12018108 2018YFA0108301 20SG10 81960146 2018YFA0800600 81872074 8200032 20410713200 81770797 91857111 81730073 TMSK-2020-102

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 1 区 生物
小类 | 1 区 细胞生物学 1 区 内分泌学与代谢
最新[2025]版:
大类 | 1 区 生物学
小类 | 1 区 细胞生物学 1 区 内分泌学与代谢
第一作者:
第一作者机构: [1]Shanghai Jiao Tong Univ,Key Lab Cell Differentiat & Apoptosis Chinese,Dept Endocrinol & Metab,Minist Educ,Shanghai Diabet Inst,Affiliated Peoples Hosp 6,Shanghai 200032,Peoples R China
通讯作者:
通讯机构: [1]Shanghai Jiao Tong Univ,Key Lab Cell Differentiat & Apoptosis Chinese,Dept Endocrinol & Metab,Minist Educ,Shanghai Diabet Inst,Affiliated Peoples Hosp 6,Shanghai 200032,Peoples R China [*1]Shanghai Jiao Tong Univ, Key Lab Cell Differentiat & Apoptosis Chinese, Dept Endocrinol & Metab,Minist Educ, Shanghai Diabet Inst,Affiliated Peoples Hosp 6, Shanghai 200032, Peoples R China [2]Naval Med Univ, Changhai Hosp, Dept Urol, Shanghai 200433, Peoples R China [*2]Naval Med Univ, Changhai Hosp, Dept Urol, Shanghai 200433, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:28508 今日访问量:0 总访问量:1584 更新日期:2025-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)